Health in Mauritania, Islamic Republic of 1,161 indicators covering health for Mauritania, Islamic Republic of. IndicatorLatest Year10-yr change Rank Hypertension: diagnosis coverage among adults aged 30-79 with 43.0% 2019 up 47.8% 146th Hypertension among adults aged 30-79 years, prevalence 37.9 2019 down 4.8% 97th Hypertension effective treatment coverage (controlled hypertension) 11.1% 2019 up 109.4% 144th Hypertension: effective treatment coverage (controlled hypertension) 10.4% 2019 up 103.9% 145th Hypertension treatment coverage among adults aged 30-79 with 24.0% 2019 up 44.6% 151st Hypertension treatment coverage among adults aged 30-79 with 26.2% 2019 up 46.4% 150th Hypertension: diagnosis coverage among adults aged 30-79 with 40.5% 2019 up 48.4% 146th Hypertension among adults aged 30-79 years, prevalence, crude 34 2019 down 5.0% 120th Pneumococcal conjugate second or third-dose vaccines (PCVc) 85.0% 2025 up 19.7% 94th People with basic handwashing facilities including soap and water 57.6% 2024 down 14.7% 71st Adolescent birth rate 6.27 2019 down 17.6% 6th Rubella number unvaccinated 13,045 2023 down 60.0% 70th Estimated number of malaria cases 359,550 Cases 2024 up 65.9% 42nd Treatment success rate: previously treated TB cases 83 2022 up 16.9% 45th Medical doctors 2.61 2022 up 62.1% 149th Proportion of births attended by skilled health personnel 70.4% 2021 up 8.1% 132nd Prevalence of insufficient physical activity among adults aged 18+ 36.2% 2022 down 22.9% 53rd Prevalence of insufficient physical activity among adults aged 18+ 38.5% 2022 down 21.3% 37th Nursing and midwifery personnel 16.09 2022 up 94.6% 139th Estimated number of people (all ages) living with HIV 5,800 2025 unchanged 113th Prevalence of HIV among adults aged 15 to 49 0.1% 2025 down 50.0% 106th Cases of paralytic polio from vaccine derived viruses 1 2023 — 19th Cases of paralytic polio from wild vs vaccine derived viruses 1 2023 — 19th TB patients with known HIV status 80.0% 2023 up 12,021.2% 125th Reported number of people receiving antiretroviral therapy 4,681 2025 up 90.4% 104th Estimated antiretroviral therapy coverage among people living with HIV 81.0% 2025 up 92.9% 49th Dentists 0.31 2022 up 47.6% 135th Confirmed cases of RR-/MDR-TB 37 2023 up 3,600.0% 100th Hib3 number unvaccinated 16,306 2023 down 39.6% 85th Number of new HIV infections 200 2025 down 60.0% 108th Number of people dying from HIV-related causes 200 2025 down 60.0% 85th Capital health expenditure 0.3% 2021 up 269.0% 62nd Adolescent birth rate 6.27 per 1,000 people 2019 down 17.6% 6th Tested TB patients HIV-positive 2.5% 2023 down 97.5% 116th Cause of death, by other COVID-19 pandemic-related outcomes, ages 0-4 0.0% 2021 — 3rd Cause of death, by other COVID-19 pandemic-related outcomes, ages 5-14 1.0% 2021 — 18th Cause of death, by other COVID-19 pandemic-related outcomes, ages 5-14 1.2% 2021 — 34th Cause of death, by other COVID-19 pandemic-related outcomes, ages 5-14 1.1% 2021 — 24th Cause of death, by other COVID-19 pandemic-related outcomes, ages 15-5 2.9% 2021 — 50th Cause of death, by other COVID-19 pandemic-related outcomes, ages 15-5 5.9% 2021 — 30th Cause of death, by other COVID-19 pandemic-related outcomes, ages 15-5 4.4% 2021 — 40th Cause of death, by other COVID-19 pandemic-related outcomes, ages 60+ 3.4% 2021 — 50th Cause of death, by other COVID-19 pandemic-related outcomes, ages 60+ 6.7% 2021 — 33rd Cause of death, by other COVID-19 pandemic-related outcomes, ages 60+ 4.9% 2021 — 43rd Cause of death, by other COVID-19 pandemic-related outcomes, female 2.4% 2021 — 55th Cause of death, by other COVID-19 pandemic-related outcomes, male 4.3% 2021 — 45th Cause of death, by communicable diseases and maternal, prenatal and 46.8% 2021 down 9.8% 37th Cause of death, by injury 7.2% 2021 down 19.2% 80th Cause of death, by non-communicable diseases 42.7% 2021 up 8.7% 145th Cause of death, by other COVID-19 pandemic-related outcomes 3.4% 2021 — 50th Cause of death, by communicable diseases and maternal, prenatal and nu 87.1% 2021 down 1.8% 26th Cause of death, by communicable diseases and maternal, prenatal and nu 86.8% 2021 down 1.7% 25th Cause of death, by communicable diseases and maternal, prenatal and nu 86.9% 2021 down 1.8% 26th Cause of death, by communicable diseases and maternal, prenatal and nu 48.4% 2021 down 12.7% 51st Cause of death, by communicable diseases and maternal, prenatal and nu 41.7% 2021 down 11.0% 48th Cause of death, by communicable diseases and maternal, prenatal and nu 44.5% 2021 down 12.4% 48th Cause of death, by communicable diseases and maternal, prenatal and nu 43.3% 2021 down 13.9% 39th Cause of death, by communicable diseases and maternal, prenatal and nu 35.6% 2021 up 2.4% 47th Cause of death, by communicable diseases and maternal, prenatal and nu 39.6% 2021 down 8.1% 38th Cause of death, by communicable diseases and maternal, prenatal and nu 24.0% 2021 up 5.7% 69th ← Previous Page 11 of 20 Next →